Literature DB >> 27160868

Emergence of Serratia marcescens isolates possessing carbapenem-hydrolysing β-lactamase KPC-2 from China.

X Lin1, Q Hu1, R Zhang2, Y Hu2, X Xu3, H Lv4.   

Abstract

Eighty-three carbapenem-resistant Serratia marcescens isolates were recovered from Zhejiang Provincial People's Hospital, China. The minimum inhibitory concentrations of imipenem, meropenem, and ertapenem for all isolates were 2 to >128 μg/mL. Polymerase chain reaction indicated that 63 S. marcescens isolates produced Klebsiella pneumoniae carbapenemase (KPC)-2. Clone A (15 isolates) and clone B (41 isolates) were the two dominant clones and clone A strains were gradually replaced by clone B strains between 2011 and 2014. The results indicate that blaKPC-2-positive S. marcescens emerged in our hospital as the major mechanism of carbapenem resistance.
Copyright © 2016 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Carbapenem; Carbapenemase; ERIC–PCR; KPC-2; Resistance; Serratia marcescens

Mesh:

Substances:

Year:  2016        PMID: 27160868     DOI: 10.1016/j.jhin.2016.04.006

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  3 in total

Review 1.  Were all carbapenemases created equal? Treatment of NDM-producing extensively drug-resistant Enterobacteriaceae: a case report and literature review.

Authors:  Vindana Chibabhai; Trusha Nana; Norma Bosman; Teena Thomas; Warren Lowman
Journal:  Infection       Date:  2017-09-15       Impact factor: 3.553

2.  Complete Genome Sequence of Bacteriophage SM9-3Y Infecting Serratia marcescens.

Authors:  Yuchong Hao; Hongyan Shi; Jinghua Li; Chunyan Zhao; Honglan Huang; Yanbo Sun
Journal:  Genome Announc       Date:  2018-01-04

3.  Evaluation of loop-mediated isothermal amplification assays for rapid detection of blaKPC producing Serratia spp. in clinical specimens: A prospective diagnostic accuracy study.

Authors:  Xinwei Liu; Dayang Zou; Chunxia Wang; Xiaoqian Zhang; Dongxu Pei; Wei Liu; Yongwei Li
Journal:  Exp Ther Med       Date:  2021-02-01       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.